Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABA-gated chloride channel, primarily referring to the GABAA receptor, is a ligand-gated ion channel mediating fast inhibitory neurotransmission in the central nervous system. Activated by GABA, the primary inhibitory neurotransmitter, it is a pentameric complex with varying subunit compositions (α, β, γ, δ, ε, π, θ, and ρ). GABA binding induces conformational changes that open a chloride-selective pore, allowing Cl− ions to flow down their electrochemical gradient, hyperpolarizing or stabilizing the neuronal membrane and inhibiting action potential firing. Allosteric modulators like benzodiazepines and barbiturates enhance or inhibit channel opening.
Binding of GABA opens chloride-selective pore, leading to Cl- influx and hyperpolarization/stabilization of membrane potential.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid (GABA)-gated chloride channel (GABAA receptor).